Annexon, Inc.
Anti-complement factor C1q antibodies and uses thereof
Last updated:
Abstract:
The present invention provides anti-C1q antibodies and methods of using the same.
Status:
Grant
Type:
Utility
Filling date:
4 Jan 2019
Issue date:
17 Mar 2020